OnDemand WTP Pricing Research

Heart attack risk rises with price of cholesterol-lowering drug, study says | UPI

July 23 (UPI) — When insurance companies refuse to cover cholesterol-lowering drugs, it puts patients at risk for stroke and heart ailments, a new study says.

Getting rejected for medications these medications puts patients at a 16 percent higher risk of having a heart attack, unstable angina, cardiac arrest or other cardiac events, according to research published Tuesday Tuesday in the journal Circulation: Cardiovascular Quality and Outcomes. Patients who were approval but didn’t fill the prescriptions for some reason were at a 21 percent risk of suffering a cardiac event.

“We heard from individuals with familial hypercholesterolemia and physicians that there were consistent difficulties getting PCSK9 inhibitors approved for coverage, even for the people these drugs are meant to help,” Kelly Myers, chief technology officer for the FH Foundation and lead author of the study, told UPI.

The study tracked the medical data and pharmacy claims for roughly 139,000 high-risk patients with familial hypercholesterolemia, or arterial plaque buildup. The researchers found insurers turned down nearly two-thirds of claims to cover the cholesterol-lowering drugs.

Read complete article here:

Heart attack risk rises with price of cholesterol-lowering drug, study says.

Post a Comment

WP-SpamFree by Pole Position Marketing